Vericel Corporation — Third Quarter 2026 Earnings Summary

Vericel Corporation reported third-quarter 2026 total net revenue of $85.4 million, representing a 26% increase from the prior year, driven by growth in its MACI and Burn Care product lines. The company achieved a net income of $14.2 million, or $0.27 per diluted share, and generated an adjusted EBITDA margin of 30%. Vericel raised its full-year 2026 revenue guidance to a range of $344 million to $346 million and increased its adjusted EBITDA margin guidance to 28%. Additionally, the company ended the quarter with $235.6 million in cash and investments and no debt.